Form 4 for VEEA VEEA INC.
Accepted 2025-08-27 00:00:00 ET · period of report 2025-08-14 · accession 0001213900-25-081278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-08-27 | 2025-08-14 | VEEA | NLabs Inc. | 10% | J - Other | $1.00 | +5.24M | 21.12M | +33% | +$5.24M |
| D | 2025-08-27 | 2025-08-14 | VEEA | NLabs Inc. | 10% | J - Other | $1.00 | +5.24M | 17.39M | +43% | +$5.24M |
| D | 2025-08-27 | 2025-08-14 | VEEA | NLabs Inc. | 10% | J - Other | $0.00 | +5.24M | 5.24M | New | $0 |
| DI | 2025-08-27 | 2025-08-14 | VEEA | NLabs Inc. | 10% | J - Other | $0.00 | +5.24M | 5.24M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-14 | J | A | 5,239,096 | $1.00 | 21,124,580 | I | — | — | (F2) Consists of shares issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F1) Shares issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which shares were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein). |
| 2 | Common | Common Stock | 2025-08-14 | J | A | 5,239,096 | $1.00 | 17,388,017 | D Owned by NLabs, Inc. | — | — | (F2) Consists of shares issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F1) Shares issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which shares were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein). |
| 3 | Derivative | Common Warrants | 2025-08-14 | J | A | 5,239,096 | $0.00 | 5,239,096 | D Owned by NLabs, Inc. | $1.10 · 2025-08-14 to 2030-08-14 | 5,239,096 Common Stock | (F4) Consists of warrants issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these warrants in this report shall not be deemed an admission of beneficial ownership of all of the reported warrants for purposes of Section 16 or for any other purpose. (F3) Warrants issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which warrants were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein). |
| 4 | Derivative | Common Warrants | 2025-08-14 | J | A | 5,239,096 | $0.00 | 5,239,096 | I | $1.10 · 2025-08-14 to 2030-08-14 | 5,239,096 Common Stock | (F4) Consists of warrants issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these warrants in this report shall not be deemed an admission of beneficial ownership of all of the reported warrants for purposes of Section 16 or for any other purpose. (F3) Warrants issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which warrants were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein). |